Vironova Biosafety AB passed SWEDAC inspection without remarks
Vironova Biosafety specializes in performing viral clearance studies for biological drugs and is the only Nordic CRO that conducts these studies in BSLII and BSLIII certified cell and virus laboratories in compliance with good laboratory practices (GLP). Services range from early R&D to market release and theoretical viral risk assessment is offered by experts with extensive regulatory experience.
The Swedish Board for Accreditation and Conformity Assessment (SWEDAC) performed a full inspection and study audit on December 20th 2017 in which Vironova Biosafety was found to operate in compliance with the principles of Good Laboratory Practice as established by the OECD and the European Community. It is specially gratifying that the GLP certificate was issued with no remarks, thus ending 2017 on a very positive note. Well done to all the staff and we’re looking forward to another great year in 2018.